Loading peptide directory…
Side-by-side
Pick up to 3 peptides and see their key facts side by side. Useful for narrowing a search before deciding which page to read in full.
1 of 3 selected.
| Field | Last updated |
|---|---|
| Aliases | Pegylated MGF, PEGylated Mechano-Growth Factor, Long-acting MGF derivative |
| Category | Other Research Peptides |
| Formula | — |
| Molecular weight | — |
| Half-life | ~1–3 days (PEG-extended; varies with PEG size) |
| Mechanism (summary) | PEG-MGF is a pegylated MGF derivative intended to preserve or extend the activity window of native MGF-like signaling. The design rationale (PEGylation as a half-life-extension strategy) is scientifically reasonable, but that does not mean PEG-MGF itself has a validated human pharmacokinetic or therapeutic profile. |
| Dosing notes | No evidence-based standard human dose exists. FDA states it has not identified human exposure data for compounded PEG-MGF drug products. Any published "protocol" lacks regulator support or established clinical evidence. |
| Storage |
No validated product-specific storage instructions located. Defensible default: cold, dry, light-protected raw material, usually -20°C or below; aliquot and avoid repeated freeze-thaw after reconstitution. |
| Read more | Full reference → |
|---|